Skip to main content

Judge Rejects Ethicon's Plea to Dismiss 120 TVM Lawsuits

Judge Rejects Ethicon's Plea to Dismiss 120 TVM Lawsuits

Judge Rejects Ethicon's Plea to Dismiss 120 TVM Lawsuits

Introduction

Ethicon Inc. had requested a Pennsylvania State Court Judge Arnold New to exclude 120 Transvaginal Mesh (TVM) lawsuits from Mass tort proceedings, stating that the venue is improper since the plaintiffs do not belong to Pennsylvania.

The Supreme Court's recent decision which allows plaintiffs to file a lawsuit in the jurisdiction where the defendant is headquartered or where the injury has allegedly occurred was the reason for Ethicon to make this move. However, in an order dated May 18, the Judge denied the plea as an “integral portion” of Ethicon Pelvic mesh device was manufactured by Secant Medical Inc., a Pennsylvania-based manufacturer. 

Judge Arnold further clarified,  “since a portion of the manufacturing process of the Gynemesh/Gynemesh PS, Prolene, Prolift, Prosima, TVT, TVT-Exact, TVT-Obturator and TVT-Secur Pelvic mesh medical devices occurs in Pennsylvania, this court’s exercise of specific personal jurisdiction comports with traditional notions of fair play and substantial justice.”

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!